Loading…
Back To Schedule
Thursday, June 18 • 5:00pm - 6:00pm
#534 OD: ON DEMAND - Bridging Bench to Bedside With Novel Biomarkers

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session
Level: Intermediate

Precision medicines, those which leverage biomarker(s) to determine who is most likely to benefit, are changing drug development. Biomarkers are expanding our understanding of disease, improving ability to identify and develop novel drug targets, understanding variation in drug response, positively impacting likelihood of drug approval and reimbursement and ultimately improving patient outcomes. Yet finding robust and clinically useful biomarkers can be like finding a needle in a haystack. Through case studies, this session will explore the value of biomarkers across drug discovery and development. It will also address the challenges of identifying and translating biomarkers to benefit patients. We will explore approaches, including through use of AI, meta-analysis of clinical trial data and real world data to increase the odds of finding robust and relevant biomarkers in increasing vast and complicated data sets.

Learning Objectives

Describe methods for biomarker discovery using artificial intelligence (AI) and large and complex data sets; Discuss how biomarkers are evaluated in clinical development; Identify best practices for biomarker data handling for use and reuse.

Chair

Anita Nelsen

Speaker

Using AI-Driven Biomarkers for Advancing Drug Development
Richard Gliklich, DrMed, MD

The Future is Here: Omics Biomarker Discovery and Strategies for Use in Clinical Trials
Misha Kapushesky, PhD


Speakers
avatar for Richard Gliklich

Richard Gliklich

Chief Executive Officer, OM1, United States
Dr. Richard Gliklich is the CEO of OM1, Inc., a real-world data, outcomes and technology company focused on using data and AI to accelerate medical research and personalize medicine, especially in chronic conditions. OM1 develops extensive data networks of participating practices... Read More →
avatar for Anita Nelsen

Anita Nelsen

Executive Vice President, Translational Medicine, Parexel, United States
Anita is a pharmaceutical industry leader who has applied pharmacogenetic, human and molecular genetics research in drug discovery and development. As Head of Translational Medicine, Anita leads a global team of scientists who are recognized thought leaders and influencers in early... Read More →
avatar for Misha Kapushesky

Misha Kapushesky

Chief Executive Officer, Genestack Ltd
As CEO of Genestack, Misha leads the company’s business growth and oversees the development of the Genestack platform. Misha has over two decades of experience in dealing with big data in genomics and has participated in and led international consortia applying bioinformatics to... Read More →

Thursday June 18, 2020 5:00pm - 6:00pm EDT
TBD Virtual Event Horsham, PA 19044
  06: PreClin Dev-EarlyPhaseCR, Session